SLFN11 binds DDX1 to counteract human mesenchymal stem/stromal cell senescence through inhibition of mTOR/eIF4E

Xin-Xin Zhu1, Yi Luo1, Jin-Yan Xu2

  • 1Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China; Guizhou Provincial Key Laboratory of Medicinal Biotechnology & Research Center for Translational Medicine in Colleges and Universities, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China; Zunyi Municipal Key Laboratory of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China.

Life Sciences
|July 6, 2026
PubMed
Abstract

Insights

Schlafen (SLFN) 11 gene protects mesenchymal stem/stromal cells (MSCs) from senescence by targeting DDX1/mTOR/eIF4E signaling. SLFN11-engineered MSCs show enhanced therapeutic efficacy and safety for cell therapy.

Area of Science:

  • Cell Biology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Mesenchymal stem/stromal cells (MSCs) are crucial for cellular therapy.
  • In vitro expansion leads to MSC senescence, reducing stemness and therapeutic potential.

Purpose of the Study:

  • Investigate the protective role of the Schlafen (SLFN) 11 gene against human MSC senescence.
  • Elucidate the mechanism of SLFN11 in preventing senescence.
  • Evaluate the efficacy and safety of SLFN11-overexpressing MSCs for therapeutic applications.

Main Methods:

  • Overexpressed SLFN11 in human MSCs using lentiviral transduction.
  • Assessed senescence markers, including cell cycle arrest, proliferation, DNA damage, and β-galactosidase activity.
  • Utilized co-immunoprecipitation and LC-MS/MS to identify molecular interactions.
  • Evaluated therapeutic efficacy in a DSS-induced ulcerative colitis mouse model.

Main Results:

  • SLFN11 overexpression attenuated MSC senescence, enhancing proliferation, clonogenicity, and stemness.
  • SLFN11 bound DDX1, inhibiting mTOR/eIF4E signaling to resist senescence.
  • SLFN11-engineered MSCs demonstrated superior protection against ulcerative colitis in mice.
  • No detectable tumorigenicity or chromosomal aberrations were observed in SLFN11-overexpressing MSCs.

Conclusions:

  • SLFN11 plays a novel role in protecting MSCs from senescence through the DDX1/mTOR/eIF4E pathway.
  • SLFN11-overexpressing MSCs represent a promising and safe cell source for therapy with preserved pluripotency and enhanced efficacy.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...